NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHLBI E-155-2016-0-US-02 Lipoprotein Targeting Protease Inhibitors and Uses US ORD 15/297,054 Abandoned
NCI E-174-2018-0-US-01 Tumor Inflltrating Lymphocytes And Methods Of Therapy US 62/409,651 Abandoned
NCI E-013-2016-0-PCT-02 METHODS OF PRODUCING T CELL POPULATIONS USING AKT INHIBITORS PCT PCT PCT/US2016/057307 Abandoned
NIAID E-101-2018-0-US-01 HIV-1 Multi-Specific Antibodies and Their Use US 62/409,097 Abandoned
NCI E-282-2016-2-US-04 Methods of Conditioning Patients For T Cell Therapy US CON 15/295,931 Abandoned
NIAID E-257-2016-0-US-01 TREATMENT OF TUMORS BY INHIBITION OF CD300F US 62/408,596 Abandoned
NCATS E-091-2016-0-US-01 METHOD OF BLOCKING TRANSMISSION OF MALARIAL PARASITE US 62/407,861 Abandoned
NCI E-207-2008-0-US-05 Dual Specific Immunotoxin for Brain Tumor Therapy US DIV 15/290,040 10072084 Issued PDF
NCI E-276-2016-0-US-01 HPPK Inhibitors Useful As Antibacterial Agents US 62/406,610 Abandoned
NCI E-001-2016-0-GB-17 ANTI-CD30 CHIMERIC ANTIGEN RECEPTORS GB EP 16784695.5 Issued
NCI E-001-2016-0-FR-16 ANTI-CD30 CHIMERIC ANTIGEN RECEPTORS FR EP 16784695.5 Issued
NCI E-001-2016-0-DE-15 ANTI-CD30 CHIMERIC ANTIGEN RECEPTORS DE EP 16784695.5 Issued
NCI E-001-2016-0-EP-07 ANTI-CD30 CHIMERIC ANTIGEN RECEPTORS EP National Stage 16784695.5 Issued
NCI E-001-2016-0-PCT-02 ANTI-CD30 CHIMERIC ANTIGEN RECEPTORS PCT PCT PCT/US2016/056262 Expired
NCI E-001-2016-0-CN-06 ANTI-CD30 CHIMERIC ANTIGEN RECEPTORS CN National Stage 201680059341.3 Issued
NCI E-001-2016-0-MX-10 ANTI-CD30 CHIMERIC ANTIGEN RECEPTORS MX National Stage MX/a/2018/004503 Abandoned
NCI E-001-2016-0-AU-03 ANTI-CD30 CHIMERIC ANTIGEN RECEPTORS AU National Stage 2016338747 Abandoned
NCI E-001-2016-0-CA-05 ANTI-CD30 CHIMERIC ANTIGEN RECEPTORS CA National Stage 3002000 Abandoned
NCI E-001-2016-0-IN-08 ANTI-CD30 CHIMERIC ANTIGEN RECEPTORS IN National Stage 201847016354 Abandoned
NCI E-247-2015-0-AU-03 SPECIFIC ANTIBODIES FOR TREATING ACUTE LYMPHOBLASTIC LEUKEMIA AU National Stage 2016335750 Issued
NIAID E-153-2015-0-US-03 Methods of Treating Cornonavirus Infection US National Stage 15/302,915 10434116 Issued PDF
NCI E-116-2014-0-US-04 Iodonium Analogs as Inhibitors of NADPH Oxidases and Other Flavin Dehydrogenases; Formulations Thereof; and Uses Thereof US National Stage 15/302,566 10131659 Issued PDF
NIAID E-145-2011-0-AU-10 Plasmodial Surface Anion Channel Inhibitors For The Treatment Or Prevention Of Malaria AU DIV 2016238979 Issued
NCI E-247-2015-0-PCT-02 IL-7R-ALPHA SPECIFIC ANTIBODIES FOR TREATING ACUTE LYMPHOBLASTIC LEUKEMIA PCT PCT PCT/US2016/055957 Expired
NCI E-247-2015-0-EP-05 IL-7R-ALPHA SPECIFIC ANTIBODIES FOR TREATING ACUTE LYMPHOBLASTIC LEUKEMIA EP National Stage 16784678.1 Pending
NIEHS E-253-2016-0-US-01 Methods and Compositions for Artificial Oocyte Activation US 62/405,803 Abandoned
NCI E-247-2015-0-CA-04 IL-7R-ALPHA SPECIFIC ANTIBODIES FOR TREATING ACUTE LYMPHOBLASTIC LEUKEMIA CA National Stage 2997809 Pending
NCI E-227-2006-5-AU-11 PREVENTION OF TISSUE ISCHEMIA, RELATED METHODS AND COMPOSITIONS AU DIV 2016238894 Issued
NCI E-263-2009-0-JP-10 Antiangiogenic Small Molecules and Methods of Use JP DIV 2016-198112 Abandoned
NCI E-148-2011-0-JP-11 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer JP DIV 198519/2016 Abandoned
NCI E-054-2017-3-US-01 Methods and Compositions for Treating Non-Hematologic Cancer US 62/405,221 Abandoned
NCI E-054-2017-2-US-01 Methods and Compositions for Treating Non-Hematologic Cancer US 62/404,754 Abandoned
NIAID E-279-2011-0-US-03 METHODS OF PRODUCING T CELL POPULATIONS ENRICHED FOR STABLE REGULATORY T-CELLS US DIV 15/284,840 11060059 Issued PDF
NCI E-054-2017-1-US-01 Methods and Compositions for Treating Non-Hematologic Cancer US 62/403,889 Abandoned
NIAID E-279-2016-0-US-01 HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE US 62/403,266 Abandoned
NCI E-173-2015-0-US-01 Module For Freezing And Storage Of Frozen Tissue US 62/403,585 Abandoned
NIA E-139-2012-2-US-11 Methods of Regulating Cannabinoid Receptor Activity-Related Disorders and Diseases US CON 15/225,643 10130593 Issued PDF
NIAID E-540-2013-0-HK-07 METHODS AND COMPOSITIONS FOR PREVENTION OF ALLERGIC REACTION HK EP 16111480.6 Issued
NCI E-080-2014-0-US-03 ZIRCONIUM-89 OXINE COMPLEX AS A CELL LABELING AGENT FOR POSITRON EMISSION TOMOGRAPHY US National Stage 15/300,883 10556916 Issued PDF
NHLBI E-273-2015-0-PCT-02 Endo-cameral Closure Device PCT PCT PCT/US2016/054961 Expired
NHLBI E-165-2015-1-PCT-01 Lentiviral Protein Delivery System For RNA-guided Genome Editing PCT PCT COMB PCT/US16/054759 Expired
NIAID E-090-2017-0-US-01 Delaying MVA Induced Apoptosis For Enhancing Immunogenicity (B13R) US 62/402,669 Abandoned
NHLBI E-207-2016-0-US-01 Method to Increase Carboxylic Acid Content on Fluorescent Nanodiamonds US 62/402,339 Abandoned
NCI E-208-2015-0-EP-05 Thalidomide Analogs and Methods of Use EP National Stage 16782148.7 Issued
NCI E-208-2015-0-CA-04 Thalidomide Analogs and Methods of Use CA National Stage 3000661 Issued
NCI E-208-2015-0-AU-03 Thalidomide Analogs and Methods of Use AU National Stage 2016330967 Issued
NIAID E-057-2011-2-US-04 Virus Like Particles (VLPs) And Method Of Use US DIV 15/279,592 10138277 Issued PDF
NINDS E-024-2016-1-PCT-01 METHODS OF TREATING AND PREVENTING AMYOTRPHIC LATERAL SCLEROSIS (ALS) PCT PCT COMB PCT/US2016/054519 Expired
NCI E-208-2015-0-PCT-02 Thalidomide Analogs and Methods of Use PCT PCT PCT/US2016/054430 Expired
NINDS E-024-2016-1-EP-02 METHODS OF TREATING AND PREVENTING AMYOTRPHIC LATERAL SCLEROSIS (ALS) EP National Stage 16781622.2 Abandoned